Associate Professor, University of Copenhagen || Co-founder and CSO, Ousia Pharma ApShttps://bsky.app/profile/clemmensenc.bsky.socialhttps://bsky.app/profile/clemmensenc.bsky.social/post/3mlup5oxa5c23New review from the lab, together with collaborators at Helmholtz Munich and Eli Lilly, now out in Nature Reviews Drug Discovery. @cbmr.science @natureportfolio.nature.com @jonaspetersen.bsky.social @johansenvbi.bsky.social https://www.nature.com/articles/s41573-026-01427-115 May 2026 06:25 +0000at://did:plc:3wlqpk45ozfrffy552fbkmjr/app.bsky.feed.post/3mlup5oxa5c23https://bsky.app/profile/clemmensenc.bsky.social/post/3lmra7sb6gk2gOur latest review, led by @anikavear.bsky.social with Michael Heneka, explores the emerging role of incretin-based therapies in neurodegenerative disease treatment https://www.nature.com/articles/s42255-025-01263-4#Ack114 Apr 2025 09:19 +0000at://did:plc:3wlqpk45ozfrffy552fbkmjr/app.bsky.feed.post/3lmra7sb6gk2ghttps://bsky.app/profile/clemmensenc.bsky.social/post/3ljl6uhxyec2kOn #WorldObesityDay, we have contributed a SnapShot to a special Issue on Obesity in @cp-cellmetabolism.bsky.social covering brain actions of the current and emerging weight loss drugs. @jonaspetersen.bsky.social @johansenvbi.bsky.social Free access link: authors.elsevier.com/a/1kiaA5WXUlaX…04 Mar 2025 19:23 +0000at://did:plc:3wlqpk45ozfrffy552fbkmjr/app.bsky.feed.post/3ljl6uhxyec2khttps://bsky.app/profile/clemmensenc.bsky.social/post/3lchzabevrc2g1/3 Kicking off my 🦋 journey with news that my lab has been awarded an ERC Consolidator Grant! Feeling incredibly proud and grateful. The project builds on our long-term focus: homeostatic control of body weight and pharmacological approaches for sustained weight loss. https://cbmr.ku.dk/news/2024/erc-grant-funds-research-to-support-weight-loss-maintenance/04 Dec 2024 11:08 +0000at://did:plc:3wlqpk45ozfrffy552fbkmjr/app.bsky.feed.post/3lchzabevrc2g